EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier

Loredana Vesci iD, Grazia Tundo, Sara Soldi iD, Serena Galletti, Daniela Stoppoloni, Roberta Bernardini iD, Anamaria Bianca Modolea, Laura Luberto iD, Emanuele Marra, Fabrizio Giorgi, Stefano Marini

Nutrients · 24.03.2024 · 16 (7) · 937

DOI: 10.3390/nu16070937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 24.03.2024. Verfasst von Loredana Vesci und 10 weiteren Autor:innen. Beteiligte Einrichtung: Corporate R&D, Alfasigma S.p.A., Via Pontina km 30.400, Pomezia, 00071 Rome, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Levilactobacillus brevis, Colitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crohn’s and ulcerative colitis are common conditions associated with inflammatory bowel disease as well as intestinal flora and epithelial barrier dysfunction. A novel fermented Lactobacillus brevis (AL0035) herein assayed in a trinitro benzene sulfonic acid (TNBS)-induced colitis mice model after oral administration significantly counteracted the body weight loss and improves the disease activity index and histological injury scores. AL0035 significantly decreased the mRNA and protein expression of different pro-inflammatory cytokines (TNFalpha, IL-1beta, IL-6, IL-12, IFN-gamma) and enhanced the expression of IL-10. In addition, the probiotic promoted the expression of tight junction proteins, such as ZO-1, keeping the intestinal mucosal barrier function to attenuate colitis symptoms in mice. Markers of inflammation cascade such as myeloperoxidase (MPO) and PPAR-gamma measured in the colon were also modified by AL0035 treatment. AL0035 was also able to reduce different lymphocyte markers’ infiltration in the colon (GATA-3, T-Bet, NK1.1) and monocyte chemoattractant protein-1 (MCP-1/CCL2), a key chemokine involved in the migration and infiltration of monocytes/macrophages in the immunological surveillance of tissues and inflammation. In colonic microbiota profile analysis through 16S rRNA sequencing, AL0035 increased the microbial diversity depleted by TNBS administration and the relative abundance of the Lactobacillaceae and Lachnospiraceae families, whereas it decreased the abundance of Proteobacteria. Altogether, these data indicated that AL0035 could lower the severity of colitis induced by TNBS by regulating inflammatory cytokines, increasing the expression of tight junction proteins and modulating intestinal microbiota, thus preventing tissue damage induced by colitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLevilactobacillus brevisColitisHumansAnimalsMiceVegetablesRNA, Ribosomal, 16SInflammationCytokinesTight Junction Proteins

Stichwörter der Autor:innen

Lactobacillus brevisfermentationgut microbiomeinflammatory bowel diseaseintestinal barrierprobiotics

Substanzen

RNA, Ribosomal, 16SCytokinesTight Junction Proteins

Autor:innen und Institutionen

  • Corporate R&D, Alfasigma S.p.A., Via Pontina km 30.400, Pomezia, 00071 Rome, Italy.
  • Department of Translational Medicine, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
  • AAT Advanced Analytical Technologies Srl, Via P. Majavacca 12, 29017 Fiorenzuola d'Arda, Italy.
  • Takis Castel Romano, 00128 Rome, Italy.
  • Centro Interdipartimentale di Medicina Comparata, Tecniche Alternative ed Acquacoltura (CIMETA), University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.

ORCID-Profile: Loredana Vesci, Sara Soldi, Roberta Bernardini, Laura Luberto

Zitieren

APA

Vesci, L., Tundo, G., Soldi, S., Galletti, S., Stoppoloni, D., Bernardini, R., Modolea, A. B., Luberto, L., Marra, E., Giorgi, F., & Marini, S. (2024). A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier. Nutrients, 16(7), 937. https://doi.org/10.3390/nu16070937

Vancouver

Vesci L, Tundo G, Soldi S, Galletti S, Stoppoloni D, Bernardini R, et al. A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier. Nutrients. 2024;16(7):937. doi:10.3390/nu16070937

BibTeX
@article{Vesci2024,
  author = {Vesci, Loredana and Tundo, Grazia and Soldi, Sara and Galletti, Serena and Stoppoloni, Daniela and Bernardini, Roberta and Modolea, Anamaria Bianca and Luberto, Laura and Marra, Emanuele and Giorgi, Fabrizio and Marini, Stefano},
  title = {A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {7},
  pages = {937},
  doi = {10.3390/nu16070937}
}
Kostenlos starten →